Bob 1 Rabbit Polyclonal Antibody
To Order Contact Us Below:
 Bob 1 Polyclonal Antibody |
|
ES8740-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Bob 1 from Human. This antibody is tested and validated for IHC, WB, ELISA |
Bob 1 Polyclonal Antibody |
|
ES8740-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Bob 1 from Human. This antibody is tested and validated for IHC, WB, ELISA |
 Bob 1 Polyclonal Conjugated Antibody |
|
C46860 |
SAB |
100ul |
EUR 476.4 |
 HRP-Goat Anti-Rabbit Secondary Antibody |
|
A12004 |
EpiGentek |
|
|
 Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated |
|
A12001 |
EpiGentek |
|
|
 Anti-Bob 1 antibody |
|
STJ98803 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to Bob 1. |
 POU2AF1 Antibody / BOB-1 |
|
V3902-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3902-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3902SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3903-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3903-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3903SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3915-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
POU2AF1 Antibody / BOB-1 |
|
V3915-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
POU2AF1 Antibody / BOB-1 |
|
V3915SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
POU2AF1 Antibody / BOB-1 |
|
V3918-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3918-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V3918SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V7324-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V7324-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V7324IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V7324SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V8023-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V8023-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
POU2AF1 Antibody / BOB-1 |
|
V8023SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
) Polyclonal BOB / GPR15 Antibody (Cytoplasmic Domain) |
|
AMM05631G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
) Polyclonal BOB / GPR15 Antibody (Extracellular Domain) |
|
AMM05632G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
 BOB.1 MonoSpecific Antibody, Unconjugated-20ug |
|
5450-MSM4-P0 |
EnQuireBio |
20ug |
EUR 279.6 |
 BOB.1 MonoSpecific Antibody, Unconjugated-100ug |
|
5450-MSM4-P1 |
EnQuireBio |
100ug |
EUR 513.6 |
 Histone H3K4 Methylation Antibody Panel Pack |
|
C10005 |
EpiGentek |
|
|
 Histone H3K9 Methylation Antibody Panel Pack |
|
C10006 |
EpiGentek |
|
|
 Histone H3K27 Methylation Antibody Panel Pack |
|
C10007 |
EpiGentek |
|
|
 Histone H3K36 Methylation Antibody Panel Pack |
|
C10008 |
EpiGentek |
|
|
 Histone H3K79 Methylation Antibody Panel Pack |
|
C10009 |
EpiGentek |
|
|
 Histone H4K20 Methylation Antibody Panel Pack |
|
C10012 |
EpiGentek |
|
|
 Histone H4 Acetylation Antibody Panel Pack |
|
C10013 |
EpiGentek |
|
|
 Histone H3 Phosphorylation Antibody Panel Pack |
|
C10014 |
EpiGentek |
|
|
 Histone H3R2 Methylation Antibody Panel Pack |
|
C10015 |
EpiGentek |
|
|
 Histone H3R8 Methylation Antibody Panel Pack |
|
C10016 |
EpiGentek |
|
|
 Histone H3R17 Methylation Antibody Panel Pack |
|
C10017 |
EpiGentek |
|
|
 Histone H3R26 Methylation Antibody Panel Pack |
|
C10018 |
EpiGentek |
|
|
 Histone H4R3 Methylation Antibody Panel Pack |
|
C10019 |
EpiGentek |
|
|
 HRP-Goat Anti-Mouse Secondary Antibody |
|
A12003 |
EpiGentek |
|
|
 DNA Methylation Antibody Panel Pack I |
|
C20000 |
EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack I |
|
C10010 |
EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack II |
|
C10011 |
EpiGentek |
|
|
 Goat Anti-Rat Secondary Antibody, Biotin Conjugated |
|
A12002 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack I – Active Genes |
|
C10000 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack I – Repression Genes |
|
C10001 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack II – Active Genes |
|
C10002 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack II – Repression Genes |
|
C10003 |
EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack III – Active Genes |
|
C10004 |
EpiGentek |
|
|
 Rabbit Polyclonal Antibody to Human Topoisomerase IIα |
|
TG2011-1 |
TopoGen |
250 units |
EUR 496.8 |
 (BOB1/2423) Antibody) BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|
BNC042423-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|
BNC042423-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL |
 (BOB1/2424) Antibody) BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|
BNC042424-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL |
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|
BNC042424-500 |
Biotium |
500uL |
EUR 654 |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL |
 (BOB1/2425) Antibody) BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|
BNC042425-100 |
Biotium |
100uL |
EUR 279.6 |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405S conjugate, Concentration: 0.1mg/mL |
Bob 1 Rabbit Polyclonal Antibody
